A crop of Silicon Valley startups offers the hope of eradicating disease by testing embryos for genetic abnormalities and the potential for future illness. But those tests come with a high price tag and ethical questions about the use of…
A crop of Silicon Valley startups offers the hope of eradicating disease by testing embryos for genetic abnormalities and the potential for future illness. But those tests come with a high price tag and ethical questions about the use of…